icad inc. (ICAD) News

icad inc. (ICAD): $1.54

0.02 (+1.32%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Filter ICAD News Items

ICAD News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ICAD News Highlights

  • ICAD's 30 day story count now stands at 2.
  • Over the past 13 days, the trend for ICAD's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about ICAD are DEC and HUGE.

Latest ICAD News From Around the Web

Below are the latest news stories about ICAD INC that investors may wish to consider to help them evaluate ICAD as an investment opportunity.

iCAD Expands Executive Sales Leadership Team as Business Grows

Bill Keyes shifts and expands his role to Senior Vice President, Global Sales Operations and Peter Graham joins iCAD as Senior Vice President, North American Sales to accelerate growth while organization adds new products and partnerships.NASHUA, N.H., Dec. 18, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader in innovative cancer-detection solutions, today announced the expansion of its sales leadership with the addition of Peter Graham, as Senior Vice Presi

Yahoo | December 18, 2023

Wealth Accumulation: 3 Stocks with Multibagger Potential

While it’s never easy to identify multibagger stocks, this may be one of the best times in decades to “swing for the fences” by buying undervalued growth names that are well-positioned to at least triple over the next few years. Amid excessive worries about interest rates, the Street has pushed down many unprofitable, high-potential companies’ stocks to absurdly low levels. Now that those fears are dissipating, these firms are well-positioned to make huge comebacks. Interest rates recently dropp

Yahoo | December 5, 2023

iCAD’s AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare

Key apps from the iCAD Breast Health Suite are now integrated with GE HealthCare’s new MyBreastAI Suite*AI applications streamline workflow and support clinicians in delivering more personalized breast care, including cancer detection, density assessment, and recommendations NASHUA, N.H., Nov. 28, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader in innovative cancer-detection solutions, today announced that key artificial intelligence (AI) powered solutions

Yahoo | November 28, 2023

iCAD’s ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease

New research presented at Radiological Society of North America annual meeting confirms ability of ProFound Breast Health Suite to predict a woman’s one to two-year risk for breast canceriCAD unveils new solution that assesses calcium deposits in the breast arteries as a proxy for hidden cardiovascular disease, the leading cause of death for women in the U.S.Dr. Emily Conant, Perelman School of Medicine, University of Pennsylvania, to present how iCAD’s 4th generation Breast AI is harnessing inn

Yahoo | November 27, 2023

Discover Future Growth Stocks: 3 Penny Stocks Poised for Massive Returns

As the Street realizes that we're in the early stages of the business cycle, penny stocks should boom.

Larry Ramer on InvestorPlace | November 22, 2023

iCAD and CancerIQ Announce Partnership to Integrate AI-Enabled Technology With Best-in-Class Risk Assessment and Care Management Platform Offering A Comprehensive Breast Health Care Solution

Offering radiology the most complete breast health solution, including breast density assessment, breast cancer detection, and thorough risk evaluation, including lifetime, genetic, and short-term 1- or 2-year AI-riskPartnership to expand access to ProFound Breast Health Suite and CancerIQ’s platform to benefit patients across thousands of facilities NASHUA, N.H. and CHICAGO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader in innovative cancer-dete

Yahoo | November 20, 2023

This iCAD Insider Increased Their Holding In The Last Year

Insiders were net buyers of iCAD, Inc.'s ( NASDAQ:ICAD ) stock during the past year. That is, insiders bought more...

Yahoo | November 16, 2023

iCAD to Participate in the 14th Annual Craig-Hallum Alpha Select Conference

NASHUA, N.H., Nov. 14, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today announced that Dana Brown, President and Chief Executive Officer and Eric Lonnqvist, Chief Financial Officer, will participate at the 14th Annual Craig-Hallum Alpha Select Conference on Thursday, November 16th. The conference will be held at the Sheraton New York Times Square in Ne

Yahoo | November 14, 2023

iCAD Reports Financial Results for Third Quarter Ended September 30, 2023

Company to host conference call and webcast today at 4:30 PM ETNASHUA, N.H., Nov. 13, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the three and nine months ended September 30, 2023. Highlights: Completed sale of Xoft, its therapy business line, to Elekta thereby enabling the Company to focus exclusi

Yahoo | November 13, 2023

7 Biotech Stocks to Buy for Big-Time Gains

Biotech stocks can be big winners because they're at the forefront of scientific innovation and push the boundaries of medical research.

Louis Navellier and the InvestorPlace Research Staff on InvestorPlace | November 10, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!